Prediabetes screening: Questionable benefits in the golden years

Irrespective of the definition and diagnostic criteria used, the term prediabetes denotes a state of dysmetabolism with a high risk of progression to diabetes mellitus. Although diabetes-related complications may already be evident among individuals with prediabetes, interventions at this stage prim...

Full description

Bibliographic Details
Main Authors: Dimitrios Tsilingiris, Natalia G. Vallianou, Maria Dalamaga
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Metabolism Open
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589936821000153
_version_ 1819014220653527040
author Dimitrios Tsilingiris
Natalia G. Vallianou
Maria Dalamaga
author_facet Dimitrios Tsilingiris
Natalia G. Vallianou
Maria Dalamaga
author_sort Dimitrios Tsilingiris
collection DOAJ
description Irrespective of the definition and diagnostic criteria used, the term prediabetes denotes a state of dysmetabolism with a high risk of progression to diabetes mellitus. Although diabetes-related complications may already be evident among individuals with prediabetes, interventions at this stage primarily aim to hinder the development of overt hyperglycemia rather than to prevent complications. Current recommendations for prediabetes testing are common across all adult age categories. Recent evidence arising from the prospective investigation of the natural course of prediabetes among elderly individuals pose questions regarding the benefits of meticulous prediabetes screening in this age group. In view of this and due to the lack of sufficient data to concretely support a positive impact of further preventive strategies among older individuals, screening recommendations should be reevaluated to target selected elderly individuals who are most likely to benefit in terms of quality of life and prognosis. Further therapeutic measures should be tailored to the inherent features of this frail age group, in order to exert a meaningful effect on overall health status.
first_indexed 2024-12-21T02:12:23Z
format Article
id doaj.art-cec17154a2b84402bcd9cf6e51e13bae
institution Directory Open Access Journal
issn 2589-9368
language English
last_indexed 2024-12-21T02:12:23Z
publishDate 2021-06-01
publisher Elsevier
record_format Article
series Metabolism Open
spelling doaj.art-cec17154a2b84402bcd9cf6e51e13bae2022-12-21T19:19:20ZengElsevierMetabolism Open2589-93682021-06-0110100091Prediabetes screening: Questionable benefits in the golden yearsDimitrios Tsilingiris0Natalia G. Vallianou1Maria Dalamaga2Corresponding author. Richard-Kuhn-Str. 1, 69123, Heidelberg, Germany.; First Department of Propaedeutic Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Laiko General Hospital, 17 St Thomas Street, 11527, Athens, GreeceFirst Department of Internal Medicine, Evangelismos General Hospital, 45-47 Ipsilantou Str, 10676, Athens, GreeceCorresponding author. Clinical Biochemistry, National and Kapodistrian University of Athens, Medical School, Mikras Asias #27, Goudi, 11527, Athens, Greece.; Department of Biological Chemistry, School of Medicine, National and Kapodistrian University of Athens, 75 Mikras Asias, 11527, Athens, GreeceIrrespective of the definition and diagnostic criteria used, the term prediabetes denotes a state of dysmetabolism with a high risk of progression to diabetes mellitus. Although diabetes-related complications may already be evident among individuals with prediabetes, interventions at this stage primarily aim to hinder the development of overt hyperglycemia rather than to prevent complications. Current recommendations for prediabetes testing are common across all adult age categories. Recent evidence arising from the prospective investigation of the natural course of prediabetes among elderly individuals pose questions regarding the benefits of meticulous prediabetes screening in this age group. In view of this and due to the lack of sufficient data to concretely support a positive impact of further preventive strategies among older individuals, screening recommendations should be reevaluated to target selected elderly individuals who are most likely to benefit in terms of quality of life and prognosis. Further therapeutic measures should be tailored to the inherent features of this frail age group, in order to exert a meaningful effect on overall health status.http://www.sciencedirect.com/science/article/pii/S2589936821000153DiabetesGlycated hemoglobinGlucosePrediabetesScreening
spellingShingle Dimitrios Tsilingiris
Natalia G. Vallianou
Maria Dalamaga
Prediabetes screening: Questionable benefits in the golden years
Metabolism Open
Diabetes
Glycated hemoglobin
Glucose
Prediabetes
Screening
title Prediabetes screening: Questionable benefits in the golden years
title_full Prediabetes screening: Questionable benefits in the golden years
title_fullStr Prediabetes screening: Questionable benefits in the golden years
title_full_unstemmed Prediabetes screening: Questionable benefits in the golden years
title_short Prediabetes screening: Questionable benefits in the golden years
title_sort prediabetes screening questionable benefits in the golden years
topic Diabetes
Glycated hemoglobin
Glucose
Prediabetes
Screening
url http://www.sciencedirect.com/science/article/pii/S2589936821000153
work_keys_str_mv AT dimitriostsilingiris prediabetesscreeningquestionablebenefitsinthegoldenyears
AT nataliagvallianou prediabetesscreeningquestionablebenefitsinthegoldenyears
AT mariadalamaga prediabetesscreeningquestionablebenefitsinthegoldenyears